Warren P Mason Selected Research

Warren P Mason Research Topics

Disease

34	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 03/2005
22	Glioma (Gliomas) 10/2022 - 02/2005
21	Neoplasms (Cancer) 05/2022 - 08/2002
10	Oligodendroglioma 05/2022 - 02/2005
6	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 02/2005
5	Brain Neoplasms (Brain Tumor) 10/2020 - 07/2005
4	Disease Progression 01/2022 - 08/2002
2	Necrosis 05/2022 - 06/2012
2	Neoplasm Metastasis (Metastasis) 10/2020 - 03/2009
2	Medulloblastoma 10/2020 - 05/2011
2	Seizures (Absence Seizure) 08/2020 - 03/2014
2	Melanoma (Melanoma, Malignant) 05/2020 - 12/2015
2	Fatigue 11/2016 - 07/2012
2	Diarrhea 09/2015 - 07/2012
2	Encephalitis (Encephalitis, Rasmussen) 03/2014 - 01/2014
2	Lymphoma (Lymphomas) 11/2003 - 08/2003
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 10/2022
1	Edema (Dropsy) 05/2022
1	Glomus Tumor (Glomus Tumors) 03/2022
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 03/2022
1	Central Nervous System Neoplasms 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Glycogen Storage Disease Type VI (Glycogenosis Type VI) 10/2020
1	Multiple Myeloma 10/2020
1	Hematologic Neoplasms (Hematological Malignancy) 10/2020
1	Epilepsy (Aura) 08/2020
1	Guillain-Barre Syndrome 05/2020
1	Residual Neoplasm 01/2018
1	HIV Infections (HIV Infection) 11/2016
1	Chronic Hepatitis B 11/2016
1	Infections 11/2016
1	Virus Diseases (Viral Diseases) 11/2016
1	Death (Near-Death Experience) 01/2016
1	Thrombocytopenia (Thrombopenia) 01/2016
1	Thrombosis (Thrombus) 01/2016
1	Demyelinating Diseases (Demyelinating Disease) 12/2015
1	Hypersensitivity (Allergy) 09/2015
1	Venous Thromboembolism 09/2015
1	Drug Resistant Epilepsy 04/2014
1	Status Epilepticus (Complex Partial Status Epilepticus) 03/2014
1	Nausea 07/2012
1	Vomiting 07/2012
1	Myoclonus (Nocturnal Myoclonus) 10/2009
1	Laryngismus (Laryngospasm) 10/2009
1	Cerebellar Ataxia (Dysmetria) 10/2009
1	Ataxia (Dyssynergia) 10/2009

Drug/Important Bio-Agent (IBA)

35	Temozolomide (Temodar)FDA LinkGeneric 10/2022 - 03/2005
6	Bevacizumab (Avastin)FDA Link 05/2022 - 05/2015
5	Pharmaceutical PreparationsIBA 10/2020 - 07/2005
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2013
3	MethyltransferasesIBA 10/2018 - 02/2006
3	Lomustine (CCNU)FDA Link 05/2017 - 06/2013
3	Vincristine (Oncovin)FDA LinkGeneric 05/2017 - 06/2013
3	Procarbazine (Matulane)FDA Link 05/2017 - 06/2013
3	Alkylating AgentsIBA 06/2010 - 07/2005
2	trametinibIBA 03/2022 - 01/2022
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 06/2013
2	Monoclonal AntibodiesIBA 12/2015 - 07/2008
2	EnzymesIBA 09/2015 - 12/2012
2	Angiogenesis InhibitorsIBA 05/2015 - 05/2012
2	ErbB Receptors (EGF Receptor)IBA 03/2015 - 02/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 06/2010
2	Anticonvulsants (Antiepileptic Drugs)IBA 04/2014 - 12/2012
2	AntibodiesIBA 03/2014 - 10/2009
1	GadoliniumIBA 05/2022
1	SteroidsIBA 05/2022
1	dabrafenibIBA 01/2022
1	HhAntag691IBA 10/2020
1	Bortezomib (Velcade)FDA Link 10/2020
1	marizomibIBA 10/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2020
1	Proteasome InhibitorsIBA 10/2020
1	cabozantinibIBA 01/2017
1	CTLA-4 AntigenIBA 12/2015
1	IpilimumabIBA 12/2015
1	NivolumabIBA 12/2015
1	PX-866IBA 09/2015
1	CilengitideIBA 05/2015
1	AfatinibIBA 03/2015
1	epidermal growth factor receptor VIIIIBA 03/2015
1	ChromatinIBA 01/2015
1	AntigensIBA 03/2014
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 06/2013
1	Everolimus FDA Link 12/2012
1	3- (4- ((4- chlorophenyl)sulfonyl)- 4- (2,5- difluorophenyl)cyclohexyl)propanoic acidIBA 07/2012
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 07/2012
1	diazepinomicinIBA 04/2012
1	GABA-A Receptors (GABA(A) Receptor)IBA 04/2012
1	CationsIBA 10/2009
1	AutoantibodiesIBA 10/2009

Therapy/Procedure

29	Radiotherapy 01/2022 - 08/2002
26	Drug Therapy (Chemotherapy) 01/2022 - 08/2002
20	Therapeutics 10/2020 - 08/2002
3	Chemoradiotherapy 10/2022 - 12/2005
1	Conformal Radiotherapy 01/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021
1	Cognitive Training 05/2019
1	Oral Administration 11/2016
1	Aftercare (After-Treatment) 12/2015
1	Immunotherapy 12/2015